Company Profile
Zimmer Biomet Stock Price, News & Analysis
- Ticker:
- ZBH
- Exchange:
- NYSE
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NYSE, Zimmer Biomet is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
87.57 USD (+0.55%)
Close
Last updated: June 23, 2026 at 00:00
16.94B USD
Market cap
Why the stock is moving
ZBH is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Zimmer Biomet is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NYSE, Zimmer Biomet is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Zimmer Biomet follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Zimmer Biomet sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Zimmer Biomet (ZBH)?
Zimmer Biomet (ZBH) most recently closed at 87.57 USD, a +0.55% move versus the previous session.
What is the market cap of Zimmer Biomet (ZBH)?
Zimmer Biomet currently has a market capitalization of 16.94B USD on BioPharmSignal.
What does Zimmer Biomet do?
Zimmer Biomet is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is ZBH stock listed?
Zimmer Biomet (ZBH) is associated with NYSE, Headquartered in the United States and listed on NYSE, Zimmer Biomet is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is Zimmer?
Zimmer Biomet is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is Zimmer Biomet targeting with Zimmer?
Zimmer Biomet is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Biomet?
Zimmer Biomet is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.